Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (205)	3/27/2002 1:41:55 PM
From: tuck	Read Replies (1) \| Respond to of 897

Wilder, Care to add some color to your negative comment about GNTA's chart? Also, I'm trying to get an idea of how Genasense might do in its various trials. Have you looked at this at all? Further, it seems their Ganite product might sell; hypercalcemia a good market, and what I can dig up seems to show Ganite is competitive in efficacy. This seems worth looking into. The premium on the options makes naked calls tempting. Anyhow, adding to the watchlist. Replacing GLFD, which doesn't have much downside left now. rkrw says Aquavan looks interesting, too; I know nothing about it. Cheers, Tuck